Frank L. Douglas
Douglas graduated from Lehigh University, received his M.D. and Ph.D. degrees from Cornell University, completed an internship and residency in internal medicine at Johns Hopkins Medical Institution, and a fellowship in neuroendocrinology at the National Institutes of Health. Douglas taught clinical pharmacology at the Pritzker School of Medicine before becoming a professor of practice at MIT and establishing the Center for Biomedical Innovation Management. Prior to joining MIT, Douglas was EVP and Member of the Board of Management of Aventis AG. He was twice named Pharmaceutical R&D Director of the Year, received the Black History Maker Award in 2007, and in 2010 was named a GQ Magazine and Geoffrey Beane Foundation Rockstar of Science.
Douglas is currently president and CEO of Austen BioInnovation Institue in Akron and currently sits on the Board of Trustees at Lehigh University and Johann Wolfgang Goethe University Frankfurt am Main as well as the board of directors at the Kauffman Foundation, Battel, NitroMed, Gene Logic, and Altanos Pharmaceuticals Holding.
- MIT Center for Biomedical Innovation biography
- Discrimination in academia – The Scientist article by Douglas